News AI returns voice to paralysed woman after 18 years A stroke survivor has been given back the ability to speak for the first time in 18 years, after a breakthrough
News Biogen trumpets data from ALS trial as FDA decision looms After a torrid couple of years, Biogen can be forgiven for making the most of new data on its tofersen drug for amyotrophic lateral sclerosis (ALS) – with an elevated status among its pipel
News AI-discovered candidates show promise in ALS Candidates slow down motor neurone death in patient samples.
Digital Sponsored Antiviral development in the age of AI: From pre-IND to earl... hVIVO experts discuss how advancements in AI and machine learning are pushing industry beyond the bounds of a traditional "one virus, one drug" model.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.
